Your funds, side by side
The lines these funds hold in common, and the companies you own through them. Weights are the ones each document states, with no currency conversion.
- Biotechnology Fund Rydex Series Funds · 71 lines · as of Mar 31, 2026 · 100.0 %
Add a second fund to see what the two hold in common.
The companies you hold through them
A company's weight in the portfolio is its weight inside each fund, times that fund's share of the portfolio. With no amounts given, the funds weigh the same.
| Holding | Biotechnology Fund |
|---|---|
| AbbVie Inc | 7.39 % |
| Amgen Inc | 5.23 % |
| Gilead Sciences Inc | 4.96 % |
| Vertex Pharmaceuticals Inc | 4.01 % |
| Regeneron Pharmaceuticals, Inc. | 3.56 % |
| Alnylam Pharmaceuticals Inc | 2.60 % |
| Insmed Inc | 2.45 % |
| BEONE MEDICINES LTD | 2.29 % |
| Natera Inc | 2.09 % |
| United Therapeutics Corp | 2.07 % |
| Biogen Inc | 2.01 % |
| Royalty Pharma PLC | 1.98 % |
| Illumina Inc | 1.74 % |
| Revolution Medicines Inc | 1.69 % |
| Moderna Inc | 1.65 % |
| AstraZeneca PLC | 1.60 % |
| Argenx SE | 1.60 % |
| Incyte Corp | 1.56 % |
| Viatris Inc | 1.50 % |
| Bridgebio Pharma Inc | 1.47 % |
| Alkermes PLC | 1.47 % |
| Jazz Pharmaceuticals PLC | 1.46 % |
| Neurocrine Biosciences Inc | 1.42 % |
| Guardant Health Inc | 1.41 % |
| Roivant Sciences Ltd | 1.40 % |
| Ionis Pharmaceuticals Inc | 1.38 % |
| Exelixis Inc | 1.29 % |
| Medpace Holdings Inc | 1.26 % |
| BioMarin Pharmaceutical Inc | 1.24 % |
| Apellis Pharmaceuticals Inc | 1.22 % |
1 funds, 71 lines read.